公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 QIAGEN BIOTECNOLOGIA BRASIL LTDA.取消

74 记录

产品持有公司班级有效性
Família QIAstat-Dx Analyzer 2.010322250133QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有
PartoSure Test10322250136QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有
AmniSure ROM Test10322250140QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有
QIAcube10322259011QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有
Pyromark Q2410322259014QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有
DIGENE CAPTURA HIBRIDA HPV10322250001QIAGEN BIOTECNOLOGIA BRASIL LTDA.III28/04/2033
CAPTURA HIBRIDA PARA CT/GC10322250007QIAGEN BIOTECNOLOGIA BRASIL LTDA.III30/03/2034
DIGENE CAPTURA HIBRIDA 2 HPV ALTO RISCO10322250019QIAGEN BIOTECNOLOGIA BRASIL LTDA.III04/10/2034
QuantiFERON®-TB GOLD Plus (QFT® Plus)10322250071QIAGEN BIOTECNOLOGIA BRASIL LTDA.III05/09/2036
artus CT/NG QS RGQ Kit10322250075QIAGEN BIOTECNOLOGIA BRASIL LTDA.III20/02/2027
artus HSV 1/2 QS RGQ10322250080QIAGEN BIOTECNOLOGIA BRASIL LTDA.III02/01/2028
ipsogen BCR-ABL1 Mbcr RGQ RT-PCR Kit10322250096QIAGEN BIOTECNOLOGIA BRASIL LTDA.III15/06/2030
QIAStat-Dx Respiratory SARS-CoV-2 Panel10322250097QIAGEN BIOTECNOLOGIA BRASIL LTDA.III25/06/2030
therascreen PIK3CA RGQ PCR Kit10322250098QIAGEN BIOTECNOLOGIA BRASIL LTDA.III30/11/2030
ipsogen JAK2 RGQ PCR Kit10322250099QIAGEN BIOTECNOLOGIA BRASIL LTDA.III14/12/2030
ipsogen® CALR RGQ PCR Kit10322250120QIAGEN BIOTECNOLOGIA BRASIL LTDA.III08/05/2033
QIAstat-Dx® Meningitis/Encephalitis10322250121QIAGEN BIOTECNOLOGIA BRASIL LTDA.III15/05/2033
QIAstat-Dx® Gastrointestinal Panel 210322250123QIAGEN BIOTECNOLOGIA BRASIL LTDA.III26/06/2033
therascreen EGFR RGQ PCR kit v310322250132QIAGEN BIOTECNOLOGIA BRASIL LTDA.III02/09/2034
QIAstat-Dx Gastrointestinal Panel 210322250135QIAGEN BIOTECNOLOGIA BRASIL LTDA.III28/07/2035
QIAstat-Dx Respiratory SARS-CoV-2 Panel10322250138QIAGEN BIOTECNOLOGIA BRASIL LTDA.III12/01/2036
QuantiFERON CMV 2 Plate Kit ELISA10322250081QIAGEN BIOTECNOLOGIA BRASIL LTDA.IV26/02/2028
artus CMV QS-RGQ kit10322250084QIAGEN BIOTECNOLOGIA BRASIL LTDA.IV04/06/2028
QIAstat-Dx Meningitis/Encephalitis (ME) Panel10322250137QIAGEN BIOTECNOLOGIA BRASIL LTDA.IV05/01/2036

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家